Accelerator Corporation Names David McElligott, Ph.D. as Chief Scientific Officer
SEATTLE--(BUSINESS WIRE)--Accelerator Corporation, a privately–held, venture capital backed biotechnology investment and development company, announced that it has named David McElligott, Ph.D. to the position of Chief Scientific Officer. Dr. McElligott replaces Patrick Gray, Ph.D. who recently joined Omeros Corporation (NASDAQ:OMER) as Scientific Fellow.